In order to further clarify the mechanism by which hAAT appears to induce greater antitumor activation of CD8+ T cells, future studies regarding hAAT may make use of tumor inoculation models in conjunction with suppression of inflammation. This evidence concerns the gene CD8A and neoplasm.